Davis's Drug Guide
concizumab
General
Pronunciation:
kon-siz-ue-mab
Trade Name(s)
- Alhemo
Ther. Class.
temporary class
antihemophilic agentsPharm. Class.
monoclonal antibodies
temporary class
tissue factor pathway inhibitor antagonistsThere's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Concizumab." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580040/4/concizumab.
Vallerand AHA, Sanoski CAC. Concizumab. Davis's Drug Guide. F.A. Davis Company; 2026. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580040/4/concizumab. Accessed June 27, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Concizumab. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580040/4/concizumab
Vallerand AHA, Sanoski CAC. Concizumab [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 June 27]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580040/4/concizumab.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - concizumab
ID - 3580040
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580040/4/concizumab
PB - F.A. Davis Company
ET - 20
DB - Pediatrics Central
DP - Unbound Medicine
ER -
